UBS Group AG - PYXIS ONCOLOGY INC ownership

PYXIS ONCOLOGY INC's ticker is and the CUSIP is 747324101. A total of 40 filers reported holding PYXIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PYXIS ONCOLOGY INC
ValueSharesWeighting
Q3 2023$5,880
-70.0%
2,955
-61.4%
0.00%
Q2 2023$19,584
+65.3%
7,650
+158.9%
0.00%
Q1 2023$11,8502,955
+1806.5%
0.00%
Q3 2022$0
-100.0%
155
-57.8%
0.00%
Q2 2022$1,000
-83.3%
367
-74.4%
0.00%
Q1 2022$6,000
-88.7%
1,432
-70.3%
0.00%
Q4 2021$53,0004,8180.00%
Other shareholders
PYXIS ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Yu Fan 69,303$137,9129.78%
Decheng Capital Management III (Cayman), LLC 326,810$650,3520.22%
Harvest Investment Services, LLC 113,894$226,6490.15%
Laurion Capital Management LP 3,170,803$6,309,8980.04%
CORNERCAP INVESTMENT COUNSEL INC 74,903$149,0570.03%
SCHULHOFF & CO INC 22,000$43,7800.02%
HHLR ADVISORS, LTD. 382,606$761,3860.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 236,195$470,0280.01%
ExodusPoint Capital Management, LP 415,072$8260.01%
Bleakley Financial Group, LLC 11,234$22,3560.00%
View complete list of PYXIS ONCOLOGY INC shareholders